• share
• favorite_border

The Advanced Psychiatric Therapeutics Clinic offers esketamine and transcranial magnetic stimulation (TMS) for patients with treatment-resistant depression.

• share
• favorite_border

Staring at the sun can damage your eyes in less than a minute. An ophthalmologist explains how to protect your vision during the 2024 eclipse.

• share
• favorite_border

UC Davis Health received a $3 million grant to support research by the Black & Brown Collective. The group is studying gun violence that disproportionately impacts marginalized communities.

• share
• favorite_border

A new study published in JAMA Neurology found human brains are getting bigger. The increased size may lead to a brain reserve, potentially reducing the risk of dementia.

• share
• favorite_border

A new study of California firearm data identifies specific risk factors associated with a legally purchased gun that is later used in a crime.

• share
• favorite_border

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.

• share
• favorite_border

UC Davis health researchers evaluated California’s mental health crisis management and prevention programs. Their report identified gaps in the system and called for more sustainable programs and community collaborations to support people with mental illness.

• share
• favorite_border

Students who use both tobacco and cannabis (marijuana) have lower grades and miss more school than students who only use one product or don’t use either. Tobacco consumption among high school students, including vaping and e-cigarettes, is a concerning 12.6%.

• share
• favorite_border

Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400 academic and clinical staff.

• share
• favorite_border

A team at UC Davis has developed a machine-learning model that can better predict which patients are at greater risk to develop hepatocellular carcinoma.

• share
• favorite_border

Could the TB vaccine be a new immunotherapy for liver cancer? A UC Davis Health study found that the century-old vaccine reduced tumors and extended survival for mice with liver cancer.

• share
• favorite_border

Scientists at the UC Davis School of Medicine may have figured out why some people have trouble digesting sorbitol, a sugar alcohol used in sugar-free gum, mints, candy and other products.

• share
• favorite_border

UC Davis Health has adopted a new technology platform, Viz.ai, to help quickly identify patients suspected of having a stroke. The hospital is the first in the Sacramento region to use the platform.

• share
• favorite_border

A new study from UC Davis Health and Oregon Health & Science University reveals significant disparities in dementia care.

• share
• favorite_border

Exposure to organophosphate ester flame retardants during pregnancy is linked to premature births, according to new research published in Environmental Health Perspectives.

• share
• favorite_border

UC Davis Health and Kaiser Permanente Division of Research received a $24 million grant from the National Institute on Aging, part of the NIH, to continue the Study of Healthy Aging in African Americans (STAR).

• share
• favorite_border

In a new case study published in New England Journal of Medicine Catalyst’s January 2024 issue, UC Davis Health shared a road map for increasing workforce diversity across the health care industry.

• share
• favorite_border

High levels of folic acid or vitamin B12 deficiency can affect fetal brain development in mice, according to a new study from researchers at the University of California, Davis.

• share
• favorite_border

A new study shows COVID-19 is not linked to long-term loss of kidney function, despite many patients hospitalized with the -19 virus who experienced acute kidney injury.

• share
• favorite_border

In an NIH-funded study, UC Davis pulmonology researchers are exploring whether delivering statins by inhalation can lead to better outcomes for people with asthma.